Dr. Sinha completed his medical training at the University of Manchester and earned his PhD from Imperial College London. He is a dual fellowship-trained specialist in intensive care and emergency medicine and completed post-doctoral research fellowships at Columbia University in New York (2015-2016) and the University of California, San Francisco (2017-2020).
Dr. Sinha’s PhD thesis explored applied clinical respiratory physiology and biostatistics. He is comprehensively trained in bench research methods, but his current research interests have shifted on the translational research spectrum and are in using big data analytics to identify biologically-driven homogeneous subgroups within heterogeneous critical-illness syndromes, with applications in precision medicine.
The majority of Dr. Sinha’s 20+ peer-reviewed publications are in the area of respiratory physiology, particularly in acute respiratory distress syndrome (ARDS). With this background and pedigree, he seamlessly made the transition to studying COVID-19 in the critical care context. He has written on the perils of premature phenotyping and the relevance of the “cytokine storm” in severe COVID-19. His expertise in this area is timely and will contribute substantially to ongoing scientific discovery at our institution.